SMAD3 and glioblastoma: Our data found that TGF-β1 could increase ROS levels in the human glioblastoma cells and was inhibited by the Smad3 inhibitor SIS3 and the NOX4 selective inhibitor GKT137831 (10 μM) (Figure 2(g)).